Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.

Aparna GoelU RahimL H NguyenC StaveMindie H Nguyen

Published in: Alimentary pharmacology & therapeutics (2017)

Rifaximin may be effective in preventing SBP in patients with cirrhosis and ascites compared to systemically absorbed antibiotics and compared to placebo.

Keyphrases

irritable bowel syndrome
cell free
clinical trial
phase iii
open label